You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Cytokeratin 18 antibody [E431-1] (ab32118)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab32118? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab32118 has been referenced in 5 publications.

  1. Lorenzatti G et al. CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer. J Cell Sci 124:1752-8 (2011). PubMed: 21525039
  2. Gonzalez-Suarez E et al. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 468:103-7 (2010). IHC-P; Mouse. PubMed: 20881963
  3. Li X et al. Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia. Am J Pathol 175:1246-54 (2009). IHC-P; Mouse. PubMed: 19661437
  4. Pratt MA et al. The canonical NF-kappaB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population. Oncogene 28:2710-22 (2009). WB; Mouse. PubMed: 19483731
  5. Sheahan S et al. TGFbeta induces apoptosis and EMT in primary mouse hepatocytes independently of p53, p21Cip1 or Rb status. BMC Cancer 8:191 (2008). ICC/IF; Mouse. PubMed: 18611248

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"